Fig. 2From: CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancerThe scatter map reflects KEGG pathways and GO analysis of DEGs in enrichment analyses. A The KEGG pathways which the DEGs enriched was shown in scatter map. B The GO analysis which the DEGs enriched was shown in scatter mapBack to article page